Following the unconvincing H1, Korian released a satisfactory Q3 slightly above consensus. It was marked by an organic growth of 4.1% yoy, while the reported growth reached 15.5%. Revenues year-to-date reached €2,224m, mainly growing in Belgium and Germany. In Germany, revenues grew by 66.3% on a reported basis thanks to the integration of Casa Reha, while Belgium saw the integration of Foyer de Lork making reported revenues rise by 12.9%.
27 Oct 2016
Strong organic growth and guidance confirmed
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong organic growth and guidance confirmed
Clariane SE (CLARI:PAR) | 0 0 1.9% | Mkt Cap: 1,957m
- Published:
27 Oct 2016 -
Author:
Lionel Pellicer -
Pages:
2
Following the unconvincing H1, Korian released a satisfactory Q3 slightly above consensus. It was marked by an organic growth of 4.1% yoy, while the reported growth reached 15.5%. Revenues year-to-date reached €2,224m, mainly growing in Belgium and Germany. In Germany, revenues grew by 66.3% on a reported basis thanks to the integration of Casa Reha, while Belgium saw the integration of Foyer de Lork making reported revenues rise by 12.9%.